Suppr超能文献

磷脂酰肌醇3-磷酸磷酸酶肌管素相关蛋白6(MTMR6)是钙激活钾通道KCa3.1的负调节因子。

The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1.

作者信息

Srivastava Shekhar, Li Zhai, Lin Lin, Liu GongXin, Ko Kyung, Coetzee William A, Skolnik Edward Y

机构信息

Skirball Institute, New York University Medical Center, 540 First Avenue, New York, NY 10016, USA.

出版信息

Mol Cell Biol. 2005 May;25(9):3630-8. doi: 10.1128/MCB.25.9.3630-3638.2005.

Abstract

Myotubularins (MTMs) belong to a large subfamily of phosphatases that dephosphorylate the 3' position of phosphatidylinositol 3-phosphate [PI(3)P] and PI(3,5)P(2). MTM1 is mutated in X-linked myotubular myopathy, and MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth syndrome. However, little is known about the general mechanism(s) whereby MTMs are regulated or the specific biological processes regulated by the different MTMs. We identified a Ca(2+)-activated K channel, K(Ca)3.1 (also known as KCa4, IKCa1, hIK1, or SK4), that specifically interacts with the MTMR6 subfamily of MTMs via coiled coil (CC) domains on both proteins. Overexpression of MTMR6 inhibited K(Ca)3.1 channel activity, and this inhibition required MTMR6's CC and phosphatase domains. This inhibition is specific; MTM1, a closely related MTM, did not inhibit K(Ca)3.1. However, a chimeric MTM1 in which the MTM1 CC domain was swapped for the MTMR6 CC domain inhibited K(Ca)3.1, indicating that MTM CC domains are sufficient to confer target specificity. K(Ca)3.1 was also inhibited by the PI(3) kinase inhibitors LY294002 and wortmannin, and this inhibition was rescued by the addition of PI(3)P, but not other phosphoinositides, to the patch pipette solution. PI(3)P also rescued the inhibition of K(Ca)3.1 by MTMR6 overexpression. These data, when taken together, indicate that K(Ca)3.1 is regulated by PI(3)P and that MTMR6 inhibits K(Ca)3.1 by dephosphorylating the 3' position of PI(3)P, possibly leading to decreased PI(3)P in lipid microdomains adjacent to K(Ca)3.1. K(Ca)3.1 plays important roles in controlling proliferation by T cells, vascular smooth muscle cells, and some cancer cell lines. Thus, our findings not only provide unique insights into the regulation of K(Ca)3.1 channel activity but also raise the possibility that MTMs play important roles in the negative regulation of T cells and in conditions associated with pathological cell proliferation, such as cancer and atherosclerosis.

摘要

肌管素(MTMs)属于一个庞大的磷酸酶亚家族,可使磷脂酰肌醇3 - 磷酸[PI(3)P]和PI(3,5)P(2)的3' 位去磷酸化。MTM1在X连锁肌管性肌病中发生突变,MTMR2和MTMR13在夏科 - 马里 - 图斯综合征中发生突变。然而,关于MTMs的调控一般机制或不同MTMs所调控的特定生物学过程,人们了解甚少。我们鉴定出一种钙激活钾通道K(Ca)3.1(也称为KCa4、IKCa1、hIK1或SK4),它通过两种蛋白上的卷曲螺旋(CC)结构域与MTMs的MTMR6亚家族特异性相互作用。MTMR6的过表达抑制了K(Ca)3.1通道活性,且这种抑制作用需要MTMR6的CC结构域和磷酸酶结构域。这种抑制具有特异性;与之密切相关的MTM1并不抑制K(Ca)3.1。然而,一种将MTM1的CC结构域替换为MTMR6的CC结构域的嵌合MTM1抑制了K(Ca)3.1,这表明MTM的CC结构域足以赋予靶标特异性。PI(3)激酶抑制剂LY294002和渥曼青霉素也抑制K(Ca)3.1,并且通过向膜片钳吸管溶液中添加PI(3)P(而非其他磷酸肌醇)可挽救这种抑制作用。PI(3)P也可挽救MTMR6过表达对K(Ca)3.1的抑制。综合这些数据表明,K(Ca)3.1受PI(3)P调控,且MTMR6通过使PI(3)P的3' 位去磷酸化来抑制K(Ca)3.1,这可能导致与K(Ca)3.1相邻的脂质微区中PI(3)P减少。K(Ca)3.1在控制T细胞、血管平滑肌细胞和一些癌细胞系的增殖中起重要作用。因此,我们的发现不仅为K(Ca)3.1通道活性的调控提供了独特见解,还提出了MTMs在T细胞的负调控以及与病理性细胞增殖相关的病症(如癌症和动脉粥样硬化)中起重要作用的可能性。

相似文献

2
Specificity of the myotubularin family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM domain.
J Biol Chem. 2006 Oct 20;281(42):31762-9. doi: 10.1074/jbc.M606344200. Epub 2006 Aug 16.
4
Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.
Mol Biol Cell. 2006 Jan;17(1):146-54. doi: 10.1091/mbc.e05-08-0763. Epub 2005 Oct 26.
5
Genetic analysis of the myotubularin family of phosphatases in Caenorhabditis elegans.
J Biol Chem. 2003 Sep 5;278(36):34380-6. doi: 10.1074/jbc.M303259200. Epub 2003 Jun 4.
6
Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells.
Mol Cell Biol. 2006 Aug;26(15):5595-602. doi: 10.1128/MCB.00352-06.
8
Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans.
Mol Biol Cell. 2004 Jan;15(1):189-96. doi: 10.1091/mbc.e03-08-0605. Epub 2003 Oct 17.
9
Myotubularin phosphatases: policing 3-phosphoinositides.
Trends Cell Biol. 2006 Aug;16(8):403-12. doi: 10.1016/j.tcb.2006.06.001. Epub 2006 Jul 7.
10
Caenorhabditis elegans myotubularin MTM-1 negatively regulates the engulfment of apoptotic cells.
PLoS Genet. 2009 Oct;5(10):e1000679. doi: 10.1371/journal.pgen.1000679. Epub 2009 Oct 9.

引用本文的文献

1
KCNN4 as a genomic determinant of cytosolic delivery by the attenuated cationic lytic peptide L17E.
Mol Ther. 2025 Feb 5;33(2):595-614. doi: 10.1016/j.ymthe.2024.12.050. Epub 2025 Jan 1.
2
The Myotubularin Related Proteins and the Untapped Interaction Potential of Their Disordered C-Terminal Regions.
Proteins. 2025 Apr;93(4):831-854. doi: 10.1002/prot.26774. Epub 2024 Nov 30.
3
Vasoactive intestinal peptide excites GnRH neurons via KCa3.1, a potential player in the slow afterhyperpolarization current.
Front Cell Neurosci. 2024 Apr 3;18:1354095. doi: 10.3389/fncel.2024.1354095. eCollection 2024.
4
Recent advances of myotubularin-related (MTMR) protein family in cardiovascular diseases.
Front Cardiovasc Med. 2024 Mar 11;11:1364604. doi: 10.3389/fcvm.2024.1364604. eCollection 2024.
6
Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis.
Front Immunol. 2022 Oct 5;13:997621. doi: 10.3389/fimmu.2022.997621. eCollection 2022.
7
An Overview of Class II Phosphoinositide 3-Kinases.
Curr Top Microbiol Immunol. 2022;436:51-68. doi: 10.1007/978-3-031-06566-8_2.
8
10
Piezo1 activation using Yoda1 inhibits macropinocytosis in A431 human epidermoid carcinoma cells.
Sci Rep. 2022 Apr 15;12(1):6322. doi: 10.1038/s41598-022-10153-8.

本文引用的文献

1
K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity.
J Immunol. 2004 Jul 15;173(2):776-86. doi: 10.4049/jimmunol.173.2.776.
2
Biochemistry. Oily barbarians breach ion channel gates.
Science. 2004 Apr 9;304(5668):223-4. doi: 10.1126/science.1097439. Epub 2004 Mar 18.
3
Potassium channels as therapeutic targets for autoimmune disorders.
Curr Opin Drug Discov Devel. 2003 Sep;6(5):640-7.
4
Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans.
Mol Biol Cell. 2004 Jan;15(1):189-96. doi: 10.1091/mbc.e03-08-0605. Epub 2003 Oct 17.
5
Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
Circulation. 2003 Sep 2;108(9):1119-25. doi: 10.1161/01.CIR.0000086464.04719.DD. Epub 2003 Aug 25.
6
Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases.
Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R285-92. doi: 10.1093/hmg/ddg273. Epub 2003 Aug 12.
7
Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9.
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9768-73. doi: 10.1073/pnas.1333958100. Epub 2003 Jul 30.
8
Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP.
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8660-5. doi: 10.1073/pnas.1033097100. Epub 2003 Jul 7.
9
Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation.
Eur J Pharmacol. 2003 Jun 27;471(3):157-64. doi: 10.1016/s0014-2999(03)01825-9.
10
Genetic analysis of the myotubularin family of phosphatases in Caenorhabditis elegans.
J Biol Chem. 2003 Sep 5;278(36):34380-6. doi: 10.1074/jbc.M303259200. Epub 2003 Jun 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验